Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

New understanding and treatments for hair loss are improving, but more research is needed.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

More precise, personalized therapies are needed for autoimmune diseases.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Ebastine may help regrow hair in alopecia areata patients.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Microneedles can cause side effects like infection and allergic reactions, and precautions like test spots and sunscreen are recommended.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

About 61% of women who had COVID-19 experienced hair loss afterward.

A fungal infection developed on a herpes scar and was successfully treated with antifungal medication.

The research found that chickenpox virus spreads in skin through blood then to skin cells, while shingles virus moves from nerves to hair follicle areas before infecting skin cells.